Sequoia China joins US-based $155m ArriVent Biopharma's Series B round

The firm has so far raised a total of $300 million.

Related Keywords

Zhang Lei ,Guizhou ,China ,Shanghai ,Arrivent Biopharma ,Allist Pharmaceuticals ,Hillhouse Capital Group ,Unicorn Capital Partners ,Pennsylvania Based Arrivent Biopharma ,Sofinnova Investments ,General Catalyst ,Catalio Capital Management ,Shanghai Healthcare Capital ,Sequoia China ,Terra Magnum Capital Partners ,Unicorn Capital Partners Limited ,Infinitum Asset Management ,Lilly Asia Ventures ,Octagon Capital Advisors ,Sirona Capital ,Zoo Capital ,Aarvik Therapeutics ,